Ana E RodrÃguez-Soto1, Michael C Langham1, Nadav Schwartz2, and Felix W Wehrli1
1Department of Radiology, University of Pennsylvania, Philadelphia, PA, United States, 2Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Pennsylvania, Philadelphia, PA, United States
Synopsis
The development of methods to
assess placental oxygen metabolism would allow to clinically evaluate its
function. Here, we evaluated the feasibility of estimating
oxygen extraction and blood flow in some abdominal and fetal draining veins. Ovarian
veins appear to play an important role in draining blood from the uterus in the
supine position, where flow increased from the 2nd to 3rd
trimester (16.4±8.1 versus 34.3±4.1mL/min/100g). Additionally, elevation of oxygen saturation (61.6±6.6%
versus 68.3±5.0%) at the umbilical vein occurred from
the 2nd to 3rd trimester, potentially reflecting
increased fetal oxygen demand as pregnancy progresses.
PURPOSE
The
key function of the placenta is to provide oxygen and nutrients to sustain fetal
viability and growth during pregnancy. Placental dysfunction is widely accepted
as a major cause of common adverse pregnancy outcomes. However, the etiology of
abnormal placental development remains unknown. Therefore, the development of
methods that allow assessment of placental oxygen metabolism would allow to
clinically evaluate its function. The overarching goal thus would be to be able
to measure the rate of O2 supplied to and extracted from both the
fetus and the mother. While typically arterial blood is fully saturated, hemoglobin
oxygen saturation (HbO2) must be measured in the maternal venous
system draining the placenta and at the vessels of the umbilical cord, through
which O2 is delivered to the fetus. In this preliminary work we attempted identify these maternal
vessels and examine the feasibility of estimating placental oxygen consumption via
T2-based MR oximetry and phase-contrast flow quantification.METHODS
A time-of-flight scan with
the following scanning parameters was acquired for slice planning:
TR/TE=600/7ms, FOV=350×300mm2,
voxel size=1.1×1.1×3.5mm3, FA=60° and no tracking saturation
(Fig. 1). SvO2 at
internal and external iliac veins (IIV and EIV) and umbilical vein (UV) was quantified
in a group of pregnant women. Imaging parameters: T2-preparation,
TEs=0,48,96,144,192ms, bSSFP TR/TE=4.1/2.05ms, FOV=300×300mm2, voxel size=0.8×0.8×5mm3,
FA=60°, 5 averages, half-Fourier with 14 reference lines, inter-pulse interval
(τ180) of 12ms and total acquisition time to collect five TEs of 20s. Additionally, TEs were corrected as the magnetization was
temporarily stored along the longitudinal axis (decaying with T1)
during the execution of refocusing pulses1 and a
three-parameter fit was used to derive T2.2 The T2 of blood was then converted to SvO2
using the Luz-Meiboom model as described by Wright et al $$$\frac{1}{T_2}=\frac{1}{T_{2o}}+K(1-HbO_2)^2$$$.3 The parameter K is the sensitivity of the sequence to
detect differences in HbO2
and T2o is the T2 of fully oxygenated blood;
both depending on Bo and sequence-specific imaging
parameters. K and T2o values were determined beforehand
for this specific sequence. The rate of O2 supplied and extracted is
quantified in units per time and mass. Therefore, volumetric blood flow rate $$$(\dot{Q})$$$ was also estimated in these vessels
using phase-contrast MRI (VENC=10 to 20 cm/s, FOV=256×256mm2, voxel size=0.8×0.8×5mm3, and FA=25°). $$$\dot{Q}$$$ was
normalized to expected average fetal weight according to gestational age (GA).4RESULTS
Ten women in the 2nd
and 3rd trimester of pregnancy (average GA: 28.3±3.3wks, range 23-32wks) have been studied so far (1.5T Siemens Avanto). Two flexible body coils placed superiorly
and inferiorly to the pregnant abdomen were used. Not all measurements were possible
in every participant due to fetal motion or flow artifact from surrounding
arteries (Fig. 2A, white circle). Of
note is ovarian vein unilateral enlargement found in 5 participants (Figs. 1 and 3C). The values of T2o and K used were 169ms and 17.6Hz, respectively. A general trend observed is decreasing SvO2 in the EIVs (right and left R2=0.50,
p=0.07) with GA; and similarly in both IIVs (Fig. 3A). Total $$$\dot{Q}$$$ in the right EIV and left IIV were found
to decrease with GA (R2=0.85, p=0.004, Fig. 3B), while increasing in the ovarian veins (R2=0.84,
p=0.04, Figs. 3C-D). SvO2
and $$$(\dot{Q})$$$ measurements at the UV were taken
directly at the cord of fetuses of GA>30wks and in the intra-abdominal UV in
those of GA<30wks (Fig. 4). $$$\dot{Q}$$$ significantly increased with GA (R2=0.72,
p=0.008, Fig. 5A); however, when $$$\dot{Q}$$$ was normalized to 100g of fetal mass this
relationship was reversed (Fig. 5B).
Simultaneously, as pregnancy progressed, SvO2 in the UV increased (R2=0.65,
p=0.05, Fig. 5C).DISCUSSION and CONCLUSIONs
Knowledge of the
hemodynamic status of the pregnant utero-placental circulation is required to
examine O2 metabolism of the placenta. IIV were targeted as they are
known to drain the pregnant uterus and placenta. However, results presented
here suggest that EIV and ovarian veins may also considerably contribute to
this task. In addition, flow in the ovarian vein appears to increase in a
similar manner as it is reduced in the right EIV as a function of GA. This may
potentially be associated with venous occlusion in supine subject position.
Although SvO2 data at the UV is limited at the moment,
estimated values are in agreement with those measured with gas analyzer from
blood collected from the UV after birth.5
Similarly, UV flow during the 3rd trimester was similar to that reported
in fetal circulation at full term.6 These results suggest increased fetal O2 demand as
pregnancy progresses. Here, we have demonstrated the feasibility of T2-based oximetry to
characterize O2 metabolism in the maternal and fetal venous
circulation.
Acknowledgements
NIH
grants U01-HD087180, RO1-HL109545, K25 HL111422.References
1. Foltz WD, Stainsby JA, Wright GA. T2 accuracy on
a whole-body imager. Magn
Reson Med.
1997;38:759-68.
2. Akçakaya M, Basha TA, Weingärtner S, Roujol
S, Berg S, Nezafat R. Improved quantitative myocardial T2 mapping:
impact of the fitting model. Magn Reson Med. 2015;74:93-105.
3. Wright G, Hu B, Macovski A. Estimating
oxygen saturation of blood in vivo with MR imaging at 1.5T. Magn Reson Med. 1991;1:275-83.
4. Archie JG, Collins JS, Lebel RR. Quantitative standards
for fetal and neonatal autopsy. Anatomic Pathology. 2008;126:256-65.
5. Richardson
B, Nodwell A, Webster K, Alshimmiri M., Gagnon R, Natale R. Fetal oxygen
saturation and fractional extraction at birth and the relationship to measures
of acidosis. Am J Obstet Gynecol. 1998;178:572-79.
6. Sun L, Macgowan CK, Sled JG, Yoo
SJ, Manlhiot C, Porayette P, Grosse-Wortmann L, Jaeggi E, McCrindle BW, Kingdom
J, Hickey E, Miller S, Seed M. Reduced fetal cerebral oxygen consumption is
associated with smaller brain size in fetuses with congenital heart disease.
Circulation. 2015;131:1313-23.